121 related articles for article (PubMed ID: 6454613)
21. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
22. Platelet function in sickle cell disease during steady state.
Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Douglas JT; Shah M; Lowe GD; Belch JJ; Forbes CD; Prentice CR
Thromb Haemost; 1982 Feb; 47(1):54-5. PubMed ID: 6176042
[TBL] [Abstract][Full Text] [Related]
24. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
25. [Platelet factor 4 and β-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease].
Wu JF; Yang YH; Pang BS
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1378-82. PubMed ID: 24025501
[TBL] [Abstract][Full Text] [Related]
26. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
27. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
28. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
29. In vivo platelet release reaction in patients with heart valve prosthesis.
Cella G; Schivazappa L; Casonato A; Molaro LG; Girolami A; Westwick J; Lane DA; Kakkar VV
Haemostasis; 1980; 9(5):263-75. PubMed ID: 6157609
[TBL] [Abstract][Full Text] [Related]
30. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
31. The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prostheses.
Pengo V; Peruzzi P; Baca M; Marzari A; Zanon F; Schivapappa L; Dalla Volta S
Eur J Clin Invest; 1989 Apr; 19(2):181-4. PubMed ID: 2499477
[TBL] [Abstract][Full Text] [Related]
32. Objective assessment of heparin requirements for hemodialysis in humans.
Ireland H; Lane DA; Curtis JR
J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
[TBL] [Abstract][Full Text] [Related]
33. Markers for endothelial injury, clotting and platelet activation in preeclampsia.
Saleh AA; Bottoms SF; Farag AM; Dombrowski MP; Welch RA; Norman G; Mammen EF
Arch Gynecol Obstet; 1992; 251(3):105-10. PubMed ID: 1605673
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of fibrinopeptide A in surgery].
Fuwa S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
[TBL] [Abstract][Full Text] [Related]
35. Measurement of platelet release substances in glomerulonephritis: a comparison of beta-thromboglobulin (beta-TG), platelet factor 4 (PF4) and serotonin assays.
Parbtani A; Frampton G; Cameron JS
Thromb Res; 1980 Jul 1-15; 19(1-2):177-89. PubMed ID: 6160636
[No Abstract] [Full Text] [Related]
36. Blood rheology after cardiac valve replacement with mechanical prostheses or bioprostheses.
Koppensteiner R; Moritz A; Schlick W; Fenzl G; Roedler S; Ehringer H; Wollner E
Am J Cardiol; 1991 Jan; 67(1):79-83. PubMed ID: 1986508
[TBL] [Abstract][Full Text] [Related]
37. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
38. Failure of platelet markers to evaluate membrane biocompatibility during a combined hemodialysis-hemoperfusion treatment.
Buccianti G; Giaretto S; Pogliani EM; Lorenz M; Valenti G; Bianchi ML; Cresseri D
Artif Organs; 1987 Oct; 11(5):416-20. PubMed ID: 2961320
[TBL] [Abstract][Full Text] [Related]
39. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
van Hulsteijn H; Fibbe W; Bertina R; Briët E
Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
[TBL] [Abstract][Full Text] [Related]
40. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
